All Stories

  1. Influence of a Serratia marcescens outbreak on the gut microbiota establishment process in low-weight preterm neonates
  2. Extracellular enzymes and adhesive properties of medically important Candida spp. strains from landfill leachate
  3. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period
  4. Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegansPseudomonas aeruginosa Infection Model
  5. Antibody reactivity against Helicobacter pylori proteins in a sample of the Spanish adult population in 2008-2013
  6. Gut eradication of VIM-1 producing ST9 Klebsiella oxytoca after fecal microbiota transplantation for diarrhea caused by a Clostridium difficile hypervirulent R027 strain
  7. New Insights into the Enterococcus faecium and Streptococcus gallolyticus subsp. gallolyticus Host Interaction Mechanisms
  8. Streptococcal Diversity of Human Milk and Comparison of Different Methods for the Taxonomic Identification of Streptococci
  9. First description of late recurrence of catheter-associated bacteraemia due to Cellulosimicrobium cellulans
  10. Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats
  11. Bronchopulmonary infection–colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study
  12. Emergence ofcfr-Mediated Linezolid Resistance in a Methicillin-Resistant Staphylococcus aureus Epidemic Clone Isolated from Patients with Cystic Fibrosis
  13. Forensic identification in teeth with caries
  14. Molecular Characterization and Genetic Diversity of ESBL-Producing Escherichia coli Colonizing the Migratory Franklin's Gulls ( Leucophaeus pipixcan ) in Antofagasta, North of Chile
  15. Susceptibility and Tolerance of Human Gut Culturable Aerobic Microbiota to Wine Polyphenols
  16. Dissemination of High-Risk Clones of Extensively Drug-Resistant Pseudomonas aeruginosa in Colombia
  17. Streptococcus gallolyticus subsp. gallolyticus from Human and Animal Origins: Genetic Diversity, Antimicrobial Susceptibility, and Characterization of a Vancomycin-Resistant Calf Isolate Carrying avanA-Tn1546-Like Element
  18. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: A double blind prospective study
  19. Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care practices
  20. Molecular characterization and antibiotic resistance of Enterococcus species from gut microbiota of Chilean Altiplano camelids
  21. Origin and Evolution of European Community-Acquired Methicillin-Resistant Staphylococcus aureus
  22. Recombination Blurs Phylogenetic Groups Routine Assignment in Escherichia coli: Setting the Record Straight
  23. High Clonal Diversity in a Non-Outbreak Situation of Clinical ESBL-Producing Klebsiella pneumoniae Isolates in the First National Surveillance Program in Cuba
  24. Individual variability in finger‐to‐finger transmission efficiency of Enterococcus faecium clones
  25. First Report of Macrolide Resistance in a Mycoplasma pneumoniae Isolate Causing Community-Acquired Pneumonia in Spain
  26. Biofilm vs. planktonic bacterial mode of growth: Which do human macrophages prefer?
  27. In VitroActivity of Fosfomycin against a Collection of Clinical Pseudomonas aeruginosa Isolates from 16 Spanish Hospitals: Establishing the Validity of Standard Broth Microdilution as Susceptibility Testing Method
  28. Enterococcus faecalis strains from food, environmental, and clinical origin produce ACE-inhibitory peptides and other bioactive peptides during growth in bovine skim milk
  29. Population Structure and Antimicrobial Susceptibility of Both Nonpersistent and Persistent Pseudomonas aeruginosa Isolates Recovered from Cystic Fibrosis Patients
  30. Detección de genes de virulencia en cepas de Enterococcus faecalis susceptibles y resistentes a aminoglucósidos
  31. Streptococcus bovis, situación taxonómica, relevancia clínica y sensibilidad antimicrobiana
  32. Antimicrobial activity, antibiotic susceptibility and virulence factors of Lactic Acid Bacteria of aquatic origin intended for use as probiotics in aquaculture
  33. Maintenance Treatment With Inhaled Ampicillin in Patients With Cystic Fibrosis and Lung Infection Due to Methicillin-Sensitive Staphylococcus aureus
  34. Tratamiento de mantenimiento con ampicilina inhalada en pacientes con fibrosis quística e infección pulmonar por Staphylococcus aureus sensible a meticilina
  35. ¿Es necesario identificar correctamente y a nivel de subespecie los aislados del grupo Streptococcus bovis?
  36. Emergence of a mutL Mutation Causing Multilocus Sequence Typing-Pulsed-Field Gel Electrophoresis Discrepancy among Pseudomonas aeruginosa Isolates from a Cystic Fibrosis Patient
  37. Sharing of Bacterial Strains Between Breast Milk and Infant Feces
  38. Translocated LPS Might Cause Endotoxin Tolerance in Circulating Monocytes of Cystic Fibrosis Patients
  39. Susceptibilidad antimicrobiana y bases genéticas de la resistencia de cepas de Enterococcus causantes de infecciones en Cuba
  40. Reidentification of Streptococcus bovis Isolates Causing Bacteremia According to the New Taxonomy Criteria: Still an Issue?
  41. Characterization ofStaphylococcus aureusstrains involved in human and bovine mastitis
  42. Wide Dispersion of ST175 Clone despite High Genetic Diversity of Carbapenem-Nonsusceptible Pseudomonas aeruginosa Clinical Strains in 16 Spanish Hospitals
  43. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem
  44. Infección bronquial crónica: el problema de Pseudomonas aeruginosa
  45. Perspectives of the potential implications of wine polyphenols on human oral and gut microbiota
  46. Metagenomic analysis of bronchoalveolar lavage samples from patients with idiopathic interstitial pneumonia and its antagonic relation with Pneumocystis jirovecii colonization
  47. Population Analysis and Epidemiological Features of Inhibitor-Resistant-TEM- -Lactamase-Producing Escherichia coli Isolates from both Community and Hospital Settings in Madrid, Spain
  48. High clonal diversity in erythromycin-resistant Streptococcus pneumoniae invasive isolates in Madrid, Spain (2000-07)
  49. Colonización-infección bronquial por Staphylococcus aureus resistente a meticilina en pacientes con fibrosis quística
  50. Staphylococcus epidermidis strains isolated from breast milk of women suffering infectious mastitis: potential virulence traits and resistance to antibiotics
  51. Longer Intestinal Persistence of Enterococcus faecalis Compared to Enterococcus faecium Clones in Intensive-Care-Unit Patients
  52. Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates
  53. High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation
  54. Los complejos clonales de alto riesgo CC2 y CC9 están ampliamente representados en cepas hospitalarias de Enterococcus faecalis aisladas en España
  55. Learning from mistakes: Taq polymerase contaminated with  -lactamase sequences results in false emergence of Streptococcus pneumoniae containing TEM
  56. Differences in biofilm development and antibiotic susceptibility among Streptococcus pneumoniae isolates from cystic fibrosis samples and blood cultures
  57. Combinations of PBPs and MurM protein variants in early and contemporary high-level penicillin-resistant Streptococcus pneumoniae isolates in Spain
  58. Alterations of the penicillin-binding proteins and murM alleles of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin in Spain
  59. Population Structure, Antimicrobial Resistance, and Mutation Frequencies of Streptococcus pneumoniae Isolates from Cystic Fibrosis Patients
  60. Scarce Evidence of Yogurt Lactic Acid Bacteria in Human Feces after Daily Yogurt Consumption by Healthy Volunteers
  61. Intestinal Colonization by vanA - or vanB2 -Containing Enterococcal Isolates of Healthy Animals in Spain
  62. Fluoroquinolone-Resistant Streptococcus pneumoniae in Spain: Activities of Garenoxacin against Clinical Isolates Including Strains with Altered Topoisomerases
  63. Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin
  64. Frequency of Mutation to Rifampin Resistance in Streptococcus pneumoniae Clinical Strains: hexA and hexB Polymorphisms Do Not Account for Hypermutation
  65. High occurrence of esp among ampicillin-resistant and vancomycin-susceptible Enterococcus faecium clones from hospitalized patients
  66. Very Low Cefotaxime Concentrations Select for Hypermutable Streptococcus pneumoniae Populations
  67. Detection of a single vanA-containing Enterococcus faecalis clone in hospitals in different regions in Spain
  68. Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.
  69. Aminoglycoside-modifying enzymes in high-level streptomycin and gentamicin resistant Enterococcus spp. in Spain